TD Asset Management Inc Purchases 10,962 Shares of GE HealthCare Technologies Inc. $GEHC

TD Asset Management Inc grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.9% during the 4th quarter, Holdings Channel reports. The institutional investor owned 388,005 shares of the company’s stock after buying an additional 10,962 shares during the quarter. TD Asset Management Inc’s holdings in GE HealthCare Technologies were worth $31,824,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in GEHC. Empowered Funds LLC increased its position in GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after buying an additional 1,665 shares during the period. Acadian Asset Management LLC bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $259,000. Cresset Asset Management LLC lifted its position in shares of GE HealthCare Technologies by 12.5% during the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock valued at $578,000 after acquiring an additional 865 shares during the period. Jump Financial LLC lifted its position in shares of GE HealthCare Technologies by 317.6% during the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after acquiring an additional 21,396 shares during the period. Finally, Gamco Investors INC. ET AL lifted its position in shares of GE HealthCare Technologies by 8.6% during the 2nd quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after acquiring an additional 320 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $64.67 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a market cap of $29.42 billion, a P/E ratio of 15.47, a P/E/G ratio of 1.46 and a beta of 0.74. The business has a fifty day simple moving average of $66.89 and a 200 day simple moving average of $75.49.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the prior year, the company earned $1.01 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on GEHC shares. Citigroup cut their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Oppenheimer reiterated an “outperform” rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Piper Sandler cut their target price on GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. BNP Paribas Exane decreased their price objective on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Finally, Barclays decreased their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 30th. Nine equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $80.21.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CFO James Saccaro acquired 3,310 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The stock was acquired at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares in the company, valued at $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Rodney F. Hochman acquired 1,618 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the transaction, the director owned 1,618 shares in the company, valued at $100,364.54. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased 21,847 shares of company stock worth $1,361,355 over the last quarter. 0.36% of the stock is currently owned by company insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.